Research Article
Gastrointestinal Elimination of Perfluorinated Compounds Using Cholestyramine and Chlorella pyrenoidosa
Table 3
Mean levels of PFCs in serum prior to treatment and stool after CSM treatment.
|
PFC species |
Pretreatment serum PFC species in ng/g Mean (SD) |
Stool PFC post-CSM in ng/g Mean (SD) |
Ratio: post-CSM stool: serum pre-treatment | | Female | Male | Female | Male | Female | Male |
| PFHxS | 48.4 (34.7) | 50.8 (28.3) | 126 (222) | 32 (19.5) | 2.60 | 0.63 | PFOS | 26 (23.7) | 29 (23.7) | 11.3 (17.1) | 8.2 (10.2) | 0.43 | 0.28 | PFOA | 2.7 (1.6) | 3.8 (1.3) | 1.4 (0.76) | 1.1 (0.41) | 0.52 | 0.29 | PFNA | 0.34 (0.40) | 0.36 (0.44) | 0.5* | 0.5* | N/A | N/A |
|
|
All PFNA post-treatment stool levels below detection limit of 1 ng/g.
|